About
Technology
Issues
FAQ
Links
Official Page
Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.